Science Applications International (SAIC) Financials

$92.93 +0.28 (+0.30%)

Closing price 05/15/2026 04:00 PM Eastern

Extended Trading

$89.82 -3.11 (-3.34%)

As of 05/15/2026 04:40 PM Eastern

Annual Income Statements for Science Applications International

This table shows Science Applications International's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025	1/30/2026
Net Income / (Loss) Attributable to Common Shareholders	117	143	179	137	226	209	277	300	477	362	358
Consolidated Net Income / (Loss)	117	143	179	137	229	211	279	303	477	362	358
Net Income / (Loss) Continuing Operations	117	143	179	137	229	211	279	303	477	362	358
Total Pre-Tax Income	183	212	214	170	286	271	358	375	620	428	387
Total Operating Income	227	263	256	220	370	390	462	501	741	563	521
Total Gross Profit	411	439	411	464	706	792	859	888	872	892	872
Total Revenue	4,315	4,442	4,454	4,659	6,379	7,056	7,394	7,704	7,444	7,479	7,262
Operating Revenue	4,315	4,442	4,454	4,659	6,379	7,056	7,394	7,704	7,444	7,479	7,262
Total Cost of Revenue	3,904	4,003	4,043	4,195	5,673	6,264	6,535	6,816	6,572	6,587	6,390
Operating Cost of Revenue	3,904	4,003	4,043	4,195	5,673	6,264	6,535	6,816	6,572	6,587	6,390
Total Operating Expenses	184	176	155	244	336	402	397	387	131	329	351
Selling, General & Admin Expense	184	166	155	158	288	352	344	374	373	339	350
Other Operating Expenses / (Income)	-	-	-	0.00	0.00	-4.00	-1.00	13	-2.00	-10	1.00
Other Special Charges / (Income)	-	-	-	-	-	-	-2.00	0.00	-240	0.00	0.00
Total Other Income / (Expense), net	-44	-51	-42	-50	-84	-119	-104	-126	-121	-135	-134
Interest Expense	44	52	44	53	90	122	105	118	120	126	128
Other Income / (Expense), net	0.00	1.00	2.00	3.00	6.00	3.00	1.00	-8.00	-1.00	-9.00	-6.00
Income Tax Expense	66	69	35	33	57	60	79	72	143	66	29
Basic Earnings per Share	$2.55	$3.21	$4.13	$3.16	$3.87	$3.60	$4.81	$5.42	$8.98	$7.23	$7.73
Weighted Average Basic Shares Outstanding	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Diluted Earnings per Share	$2.47	$3.12	$4.02	$3.11	$3.83	$3.56	$4.77	$5.38	$8.88	$7.17	$7.70
Weighted Average Diluted Shares Outstanding	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Weighted Average Basic & Diluted Shares Outstanding	45.90M	43.57M	43.30M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Cash Dividends to Common per Share	$1.21	$1.24	$1.24	$1.24	$1.48	$1.48	$1.48	$1.48	$1.48	$1.48	$1.48

This table shows Science Applications International's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025	5/2/2025	8/1/2025	10/31/2025	1/30/2026
Net Income / (Loss) Attributable to Common Shareholders	247	93	39	77	81	106	98	68	127	78	85
Consolidated Net Income / (Loss)	247	93	39	77	81	106	98	68	127	78	85
Net Income / (Loss) Continuing Operations	247	93	39	77	81	106	98	68	127	78	85
Total Pre-Tax Income	335	114	48	95	100	126	107	86	108	94	99
Total Operating Income	362	143	79	131	134	160	138	121	139	128	133
Total Gross Profit	216	229	192	213	210	237	232	209	215	227	221
Total Revenue	1,784	1,895	1,737	1,847	1,818	1,976	1,838	1,877	1,769	1,866	1,750
Operating Revenue	1,784	1,895	1,737	1,847	1,818	1,976	1,838	1,877	1,769	1,866	1,750
Total Cost of Revenue	1,568	1,666	1,545	1,634	1,608	1,739	1,606	1,668	1,554	1,639	1,529
Operating Cost of Revenue	1,568	1,666	1,545	1,634	1,608	1,739	1,606	1,668	1,554	1,639	1,529
Total Operating Expenses	-146	86	113	82	76	77	94	88	76	99	88
Selling, General & Admin Expense	88	87	114	85	77	83	94	89	75	101	85
Other Operating Expenses / (Income)	0.00	-1.00	-1.00	-3.00	-1.00	-6.00	-	-1.00	1.00	-2.00	3.00
Total Other Income / (Expense), net	-27	-29	-31	-36	-34	-34	-31	-35	-31	-34	-34
Interest Expense	29	27	32	34	31	32	29	30	31	33	34
Income Tax Expense	88	21	9.00	18	19	20	9.00	18	-19	16	14
Basic Earnings per Share	$4.60	$1.79	$0.79	$1.49	$1.59	$2.15	$2.00	$1.43	$2.72	$1.70	$1.88
Weighted Average Basic Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M
Diluted Earnings per Share	$4.56	$1.76	$0.77	$1.48	$1.58	$2.13	$1.98	$1.42	$2.71	$1.69	$1.88
Weighted Average Diluted Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M
Weighted Average Basic & Diluted Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025	1/30/2026
Net Change in Cash & Equivalents	-92	9.00	-66	94	-44	-12	-75	3.00	-15	-39	126
Net Cash From Operating Activities	226	273	217	184	458	755	518	532	396	494	609
Net Cash From Continuing Operating Activities	226	273	217	184	458	755	518	532	396	494	609
Net Income / (Loss) Continuing Operations	117	143	179	137	229	211	279	303	477	362	358
Consolidated Net Income / (Loss)	117	143	179	137	229	211	279	303	477	362	358
Depreciation Expense	62	53	46	47	131	179	165	157	142	140	149
Non-Cash Adjustments To Reconcile Net Income	24	16	27	85	42	54	62	47	-185	46	65
Changes in Operating Assets and Liabilities, net	23	61	-35	-87	49	305	38	25	-38	-54	37
Net Cash From Investing Activities	-784	-17	-22	-1,028	-47	-1,231	-292	-36	314	-35	-248
Net Cash From Continuing Investing Activities	-784	-17	-22	-1,028	-47	-1,231	-292	-36	314	-35	-248
Purchase of Property, Plant & Equipment	-20	-15	-22	-28	-21	-46	-36	-25	-27	-36	-32
Acquisitions	-764	0.00	0.00	-1,001	0.00	-1,202	-255	0.00	-8.00	0.00	-203
Purchase of Investments	-	-	0.00	0.00	-24	-6.00	-9.00	-7.00	-18	-21	-20
Divestitures	-	-	-	0.00	0.00	17	8.00	0.00	356	10	0.00
Sale and/or Maturity of Investments	-	-	0.00	0.00	3.00	9.00	6.00	4.00	6.00	12	7.00
Other Investing Activities, net	-	-2.00	0.00	1.00	-5.00	-3.00	-6.00	-8.00	5.00	0.00	0.00
Net Cash From Financing Activities	466	-247	-261	938	-455	464	-301	-493	-725	-498	-235
Net Cash From Continuing Financing Activities	466	-247	-261	938	-455	464	-301	-493	-725	-498	-235
Repayment of Debt	-89	-238	-50	-805	-274	-426	-119	-999	-441	-1,384	-2,487
Repurchase of Common Equity	-69	-180	-186	-71	-197	-34	-226	-267	-382	-558	-445
Payment of Dividends	-55	-54	-54	-52	-94	-89	-88	-83	-79	-75	-70
Issuance of Debt	670	209	25	1,859	100	1,000	116	840	160	1,499	2,745
Issuance of Common Equity	4.00	5.00	6.00	7.00	10	13	16	16	17	20	22
Cash Interest Paid	36	48	41	44	86	96	98	111	125	121	101

This table details how cash moves in and out of Science Applications International's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025	5/2/2025	8/1/2025	10/31/2025	1/30/2026
Net Change in Cash & Equivalents	-70	-41	-217	-45	-2.00	-2.00	10	-9.00	1.00	-3.00	137
Net Cash From Operating Activities	150	101	63	98	138	143	115	100	122	129	258
Net Cash From Continuing Operating Activities	148	101	63	98	136	143	115	100	122	129	258
Net Income / (Loss) Continuing Operations	247	93	39	77	81	106	98	68	127	78	85
Consolidated Net Income / (Loss)	247	93	39	77	81	106	98	68	127	78	85
Depreciation Expense	36	34	36	35	34	35	36	36	35	38	40
Non-Cash Adjustments To Reconcile Net Income	-229	14	24	12	8.00	7.00	17	15	10	22	18
Changes in Operating Assets and Liabilities, net	94	-40	-36	-26	13	-5.00	-36	-19	-50	-9.00	115
Net Cash From Investing Activities	-2.00	-10	-10	-7.00	-9.00	1.00	-20	-15	-7.00	-215	-11
Net Cash From Continuing Investing Activities	-2.00	-10	-10	-7.00	-9.00	1.00	-20	-15	-7.00	-215	-11
Purchase of Property, Plant & Equipment	-6.00	-4.00	-11	-6.00	-6.00	-9.00	-15	-8.00	-7.00	-9.00	-8.00
Purchase of Investments	-2.00	-1.00	-2.00	-4.00	-4.00	-3.00	-3.00	-4.00	-	-1.00	-15
Sale and/or Maturity of Investments	3.00	1.00	1.00	4.00	2.00	4.00	2.00	3.00	1.00	1.00	2.00
Other Investing Activities, net	-	-7.00	5.00	-1.00	-1.00	-1.00	-4.00	-6.00	-1.00	-3.00	10
Net Cash From Financing Activities	-218	-132	-270	-136	-131	-146	-85	-94	-114	83	-110
Net Cash From Continuing Financing Activities	-218	-132	-270	-136	-131	-146	-85	-94	-114	83	-110
Repayment of Debt	-100	-15	-166	-310	-296	-450	-328	-689	-550	-1,247	-1.00
Repurchase of Common Equity	-102	-103	-89	-103	-201	-121	-133	-142	-110	-95	-98
Payment of Dividends	-20	-19	-19	-20	-19	-18	-18	-19	-17	-17	-17
Issuance of Common Equity	4.00	5.00	4.00	4.00	5.00	5.00	6.00	6.00	6.00	4.00	6.00

This table presents Science Applications International's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025	1/30/2026
Total Assets	2,122	2,042	784	4,563	4,711	5,723	5,746	5,543	5,314	5,246	5,354
Total Current Assets	952	901	753	1,433	1,430	1,289	1,263	1,197	1,131	1,154	1,179
Cash & Equivalents	195	210	-	237	188	171	106	109	94	56	182
Accounts Receivable	635	539	673	1,050	1,099	962	1,015	936	914	1,000	853
Prepaid Expenses	21	27	-	47	40	56	57	58	93	78	122
Other Current Assets	33	54	14	25	19	22	21	23	30	20	22
Plant, Property, & Equipment, net	71	60	0.00	103	91	108	100	92	91	104	110
Total Noncurrent Assets	1,099	1,081	31	3,027	3,190	4,326	4,383	4,254	4,092	3,988	4,065
Goodwill	860	863	-	2,120	2,139	2,787	2,913	2,911	2,851	2,851	2,944
Intangible Assets	224	200	-	803	711	1,138	1,132	1,009	894	779	761
Other Noncurrent Operating Assets	15	18	31	104	340	401	338	320	347	358	360
Total Liabilities & Shareholders' Equity	2,122	2,042	491	4,563	4,711	5,723	5,746	5,543	5,314	5,246	5,354
Total Liabilities	1,742	1,693	165	3,064	3,284	4,171	4,117	3,839	3,529	3,669	3,854
Total Current Liabilities	688	623	94	897	1,128	1,275	1,352	1,126	1,158	1,396	982
Short-Term Debt	57	25	-	24	70	68	148	31	77	313	19
Accounts Payable	351	329	-	455	527	517	612	624	567	631	500
Accrued Expenses	280	269	94	297	405	494	365	266	265	233	262
Current Employee Benefit Liabilities	-	-	-	121	126	196	227	205	249	219	201
Total Noncurrent Liabilities	1,054	1,070	71	2,167	2,156	2,896	2,765	2,713	2,371	2,273	2,872
Long-Term Debt	1,013	1,022	-	2,065	1,851	2,447	2,370	2,343	2,022	1,907	2,468
Noncurrent Deferred & Payable Income Tax Liabilities	8.00	10	24	-	-	2.00	43	0.00	28	24	104
Other Noncurrent Operating Liabilities	33	38	47	102	305	447	352	370	321	342	300
Commitments & Contingencies	0.00	0.00	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	380	349	326	1,499	1,427	1,552	1,629	1,704	1,785	1,577	1,500
Total Preferred & Common Equity	380	349	326	1,485	1,417	1,542	1,619	1,694	1,785	1,577	1,500
Total Common Equity	380	349	326	1,485	1,417	1,542	1,619	1,694	1,785	1,577	1,500
Common Stock	215	91	-	1,132	983	1,004	838	637	337	0.00	0.00
Retained Earnings	174	260	326	367	506	627	818	1,035	1,432	1,565	1,492
Accumulated Other Comprehensive Income / (Loss)	-9.00	-2.00	-	-14	-72	-89	-37	22	16	12	8.00

This table presents Science Applications International's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024	Q1 2025	Q2 2025	Q3 2025	Q1 2026	Q2 2026	Q3 2026
Period end date	7/29/2022	10/28/2022	5/5/2023	8/4/2023	11/3/2023	5/3/2024	8/2/2024	11/1/2024	5/2/2025	8/1/2025	10/31/2025
Total Assets	5,654	5,628	5,957	5,672	5,658	5,250	5,250	5,275	5,211	5,201	5,423
Total Current Assets	1,270	1,247	1,675	1,384	1,388	1,091	1,103	1,160	1,148	1,204	1,257
Cash & Equivalents	99	53	422	352	311	49	48	46	47	48	45
Accounts Receivable	1,036	1,059	995	958	1,010	934	946	1,022	1,009	951	1,045
Prepaid Expenses	135	135	77	74	67	108	109	92	92	175	145
Other Current Assets	-	-	-	-	-	-	-	-	-	30	22
Plant, Property, & Equipment, net	95	95	91	90	89	93	95	99	102	104	108
Total Noncurrent Assets	4,289	4,286	4,191	4,198	4,181	4,066	4,052	4,016	3,961	3,893	4,058
Goodwill	2,911	2,911	2,851	2,851	2,851	2,851	2,851	2,851	2,851	2,851	2,960
Intangible Assets	1,069	1,040	980	951	923	865	836	807	750	721	779
Other Noncurrent Operating Assets	309	335	360	396	407	350	365	358	360	321	319
Total Liabilities & Shareholders' Equity	5,654	5,628	5,957	5,672	5,658	5,250	5,250	5,275	5,211	5,201	5,423
Total Liabilities	4,001	3,932	4,265	3,829	3,830	3,491	3,625	3,663	3,706	3,684	3,911
Total Current Liabilities	1,190	1,230	1,553	1,212	1,226	1,154	1,292	1,337	1,474	1,447	1,050
Short-Term Debt	0.00	15	46	62	69	90	197	220	405	448	12
Accounts Payable	853	819	809	820	840	648	639	714	668	557	627
Accrued Expenses	-	-	-	-	-	129	118	92	113	106	103
Current Employee Benefit Liabilities	337	396	277	330	317	287	338	311	288	336	308
Total Noncurrent Liabilities	2,811	2,702	2,712	2,617	2,604	2,337	2,333	2,326	2,232	2,237	2,861
Long-Term Debt	2,462	2,358	2,329	2,215	2,194	1,993	1,970	1,939	1,876	1,844	2,475
Noncurrent Deferred & Payable Income Tax Liabilities	7.00	0.00	-	-	-	29	19	12	22	132	124
Other Noncurrent Operating Liabilities	342	344	383	402	410	315	344	375	334	261	262
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	1,653	1,696	1,692	1,843	1,828	1,759	1,625	1,612	1,505	1,517	1,512
Total Preferred & Common Equity	1,643	1,686	1,692	1,843	1,828	1,759	1,625	1,612	1,505	1,517	1,512
Total Common Equity	1,643	1,686	1,692	1,843	1,828	1,759	1,625	1,612	1,505	1,517	1,512
Common Stock	723	679	563	480	395	251	63	0.00	0.00	0.00	0.00
Retained Earnings	923	981	1,113	1,340	1,413	1,489	1,551	1,602	1,494	1,508	1,504
Accumulated Other Comprehensive Income / (Loss)	-3.00	26	16	23	20	19	11	10	11	9.00	8.00

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Period end date	1/29/2016	2/3/2017	2/2/2018	2/1/2019	1/31/2020	1/29/2021	1/28/2022	2/3/2023	2/2/2024	1/31/2025	1/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,127,414.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,127,414.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	7.93
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	145	177	214	177	296	304	360	405	570	476	482
Return On Investment Capital (ROIC_SIMPLE)	-	-	-	-	-	-	-	9.93%	14.68%	12.54%	12.09%
Earnings before Interest and Taxes (EBIT)	227	264	258	223	376	393	463	493	740	554	515
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	289	317	304	272	514	578	602	650	882	694	664
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-580	246	193	-1,967	487	-432	215	477	749	525	418
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	1,255	1,186	1,207	3,351	3,160	3,896	4,041	3,969	3,790	3,741	3,805
Increase / (Decrease) in Invested Capital	725	-69	21	2,144	-191	736	145	-72	-179	-49	64
Book Value per Share	$8.36	$7.95	$7.65	$34.90	$24.55	$26.48	$28.43	$31.01	$34.29	$32.26	$33.24
Tangible Book Value per Share	($15.48)	($16.27)	($16.72)	($33.80)	($24.83)	($40.93)	($42.61)	($40.75)	($37.65)	($42.00)	($48.86)
Total Capital	1,450	1,396	1,351	3,588	3,348	4,067	4,147	4,078	3,884	3,797	3,987
Total Debt	1,070	1,047	1,024	2,089	1,921	2,515	2,518	2,374	2,099	2,220	2,487
Total Long-Term Debt	1,013	1,022	983	2,065	1,851	2,447	2,370	2,343	2,022	1,907	2,468
Net Debt	875	837	880	1,852	1,733	2,344	2,412	2,265	2,005	2,164	2,305
Capital Expenditures (CapEx)	20	15	22	28	21	46	36	25	27	36	32
Debt-free, Cash-free Net Working Capital (DFCFNWC)	126	93	152	323	184	-89	-47	-7.00	-44	15	34
Debt-free Net Working Capital (DFNWC)	321	303	296	560	372	82	59	102	50	71	216
Net Working Capital (NWC)	264	278	255	536	302	14	-89	71	-27	-242	197
Net Nonoperating Expense (NNE)	28	34	35	40	67	93	81	102	93	114	124
Net Nonoperating Obligations (NNO)	875	837	880	1,852	1,733	2,344	2,412	2,265	2,005	2,164	2,305
Total Depreciation and Amortization (D&A)	62	53	46	49	138	185	139	157	142	140	149
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$2.55	$3.33	$4.13	$3.16	$3.87	$3.60	$4.81	$5.42	$8.98	$7.23	$7.73
Adjusted Weighted Average Basic Shares Outstanding	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Adjusted Diluted Earnings per Share	$2.47	$3.22	$4.02	$3.11	$3.83	$3.56	$4.77	$5.38	$8.88	$7.17	$7.70
Adjusted Weighted Average Diluted Shares Outstanding	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$4.13	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	44.78M	43.57M	42.28M	59.32M	57.84M	58.07M	56.05M	54.20M	51.65M	47.74M	43.42M
Normalized Net Operating Profit after Tax (NOPAT)	145	184	214	247	335	346	402	405	385	476	482
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

This table displays calculated financial ratios and metrics derived from Science Applications International's official financial filings.

Metric	Q2 2024	Q3 2024	Q4 2024	Q1 2025	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026	Q3 2026	Q4 2026
Period end date	8/4/2023	11/3/2023	2/2/2024	5/3/2024	8/2/2024	11/1/2024	1/31/2025	5/2/2025	8/1/2025	10/31/2025	1/30/2026
DEI Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,127,414.00
DEI Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	45,127,414.00
DEI Earnings Per Adjusted Shares Outstanding	-	-	-	-	-	-	-	-	-	-	1.88
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Net Operating Profit after Tax (NOPAT)	267	117	64	106	109	135	126	96	163	106	114
Return On Investment Capital (ROIC_SIMPLE)	-	-	1.65%	2.76%	-	-	3.33%	2.53%	4.29%	2.66%	2.86%
Earnings before Interest and Taxes (EBIT)	364	141	80	129	131	158	136	116	139	127	133
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	400	175	116	164	165	193	172	152	174	165	173
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	515	353	243	-157	133	190	175	150	146	-123	50
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	3,768	3,780	3,790	3,793	3,744	3,725	3,741	3,739	3,761	3,954	3,805
Increase / (Decrease) in Invested Capital	-248	-236	-179	263	-24	-55	-49	-54	17	229	64
Book Value per Share	$34.33	$34.53	$34.29	$34.06	$31.72	$32.55	$32.26	$31.53	$32.36	$32.85	$33.24
Tangible Book Value per Share	($36.49)	($36.76)	($37.65)	($37.89)	($40.25)	($41.32)	($42.00)	($43.91)	($43.84)	($48.39)	($48.86)
Total Capital	4,120	4,091	3,884	3,842	3,792	3,771	3,797	3,786	3,809	3,999	3,987
Total Debt	2,277	2,263	2,099	2,083	2,167	2,159	2,220	2,281	2,292	2,487	2,487
Total Long-Term Debt	2,215	2,194	2,022	1,993	1,970	1,939	1,907	1,876	1,844	2,475	2,468
Net Debt	1,925	1,952	2,005	2,034	2,119	2,113	2,164	2,234	2,244	2,442	2,305
Capital Expenditures (CapEx)	6.00	4.00	11	6.00	6.00	9.00	15	8.00	7.00	9.00	8.00
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-118	-80	-44	-22	-40	-3.00	15	32	157	174	34
Debt-free Net Working Capital (DFNWC)	234	231	50	27	8.00	43	71	79	205	219	216
Net Working Capital (NWC)	172	162	-27	-63	-189	-177	-242	-326	-243	207	197
Net Nonoperating Expense (NNE)	20	24	25	29	28	29	28	28	36	28	29
Net Nonoperating Obligations (NNO)	1,925	1,952	2,005	2,034	2,119	2,113	2,164	2,234	2,244	2,442	2,305
Total Depreciation and Amortization (D&A)	36	34	36	35	34	35	36	36	35	38	40
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	$4.60	$1.79	$0.79	$1.49	$1.59	$2.15	$2.00	$1.43	$2.72	$1.70	$1.88
Adjusted Weighted Average Basic Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M
Adjusted Diluted Earnings per Share	$4.56	$1.76	$0.77	$1.48	$1.58	$2.13	$1.98	$1.42	$2.71	$1.69	$1.88
Adjusted Weighted Average Diluted Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	52.94M	52.06M	51.65M	51.23M	49.52M	48.88M	47.74M	46.87M	46.02M	45.13M	43.42M
Normalized Net Operating Profit after Tax (NOPAT)	94	117	64	106	109	135	126	96	97	106	114
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-

Financials Breakdown Chart

Key Financial Trends

Science Applications International (SAIC) has produced a mix of steady profitability and improving cash flow in recent quarters, with a solid operating base but rising leverage and capital allocations shaping risks and opportunities for investors. Here are the key takeaways drawn from SAIC's quarterly statements over the last four years.

Strong quarterly operating cash flow: Net cash from continuing operating activities was $258 million in Q4 2026, underscoring robust cash generation from core operations.
Estimated free cash flow remains healthy in Q4 2026: about $247 million (OCF of $258 million minus roughly $11 million in net investing cash outflows).
Dividend support for investors: SAIC has maintained a quarterly cash dividend per share of $0.37 in recent periods, providing a predictable income stream.
Financing flexibility via debt issuance: SAIC issued about $1.44 billion of debt in Q3 2026, reflecting access to capital markets to support liquidity and funding needs.
Revenue volatility: quarterly operating revenue tends to hover in the $1.75–$2.0 billion range across 2024–2026, with no clear, sustained uptrend in the near term.
Asset mix shows heavy goodwill and intangible assets: Goodwill around $2.85–$2.93 billion and intangible assets roughly $0.75–$1.0 billion, which could imply impairment risk if business conditions deteriorate.
Cash on hand remains modest: cash and equivalents typically sit around $45–$50 million in recent quarters, which may constrain liquidity if operating cash flow slows.
Rising leverage and interest burden: long-term debt sits in the ~$2.3–$2.5 billion range, contributing to increased interest costs (roughly $26–$34 million per quarter in the periods shown).
Share repurchases compress cash reserves: for example, about $98 million was spent on repurchasing common equity in Q4 2026.
Financing outflows pressuring cash balances: net cash from financing activities was negative in multiple quarters (e.g., around -$114 million in Q2 2026 and -$110 million in Q4 2026), signaling ongoing capital-allocation outlays beyond operating cash flow.

05/16/26 06:49 AM ETAI Generated. May Contain Errors.

Science Applications International Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Science Applications International's financial year ends in January. Their financial year 2026 ended on January 30, 2026.

Science Applications International's net income appears to be on an upward trend, with a most recent value of $358 million in 2026, rising from $117 million in 2016. The previous period was $362 million in 2025. See Science Applications International's forecast for analyst expectations on what's next for the company.

Science Applications International's total operating income in 2026 was $521 million, based on the following breakdown:

Total Gross Profit: $872 million
Total Operating Expenses: $351 million

Over the last 10 years, Science Applications International's total revenue changed from $4.32 billion in 2016 to $7.26 billion in 2026, a change of 68.3%.

Science Applications International's total liabilities were at $3.85 billion at the end of 2026, a 5.0% increase from 2025, and a 121.2% increase since 2016.

In the past 10 years, Science Applications International's cash and equivalents has ranged from $0.00 in 2018 to $237 million in 2019, and is currently $182 million as of their latest financial filing in 2026.

Over the last 10 years, Science Applications International's book value per share changed from 8.36 in 2016 to 33.24 in 2026, a change of 297.7%.

Related Companies

Financial statements for NASDAQ:SAIC last updated on 3/18/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Science Applications International (SAIC) Financials

Financials Breakdown Chart

Key Financial Trends

Science Applications International Financials - Frequently Asked Questions

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Science Applications International (SAIC) Financials

Annual Income Statements for Science Applications International

Quarterly Income Statements for Science Applications International

Annual Cash Flow Statements for Science Applications International

Quarterly Cash Flow Statements for Science Applications International

Annual Balance Sheets for Science Applications International

Quarterly Balance Sheets for Science Applications International

Annual Metrics And Ratios for Science Applications International

Quarterly Metrics And Ratios for Science Applications International

Financials Breakdown Chart

Key Financial Trends

Science Applications International Financials - Frequently Asked Questions

When does Science Applications International's fiscal year end?

How has Science Applications International's net income changed over the last 10 years?

What is Science Applications International's operating income?

How has Science Applications International's revenue changed over the last 10 years?

How much debt does Science Applications International have?

How much cash does Science Applications International have?

How has Science Applications International's book value per share changed over the last 10 years?

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools